135 related articles for article (PubMed ID: 8200093)
1. Presence of mucosa-specific DNA adduct in human colon: possible implication for colorectal cancer.
Umemoto A; Kajikawa A; Tanaka M; Hamada K; Seraj MJ; Kubota A; Nakayama M; Kinouchi T; Ohnishi Y; Yamashita K
Carcinogenesis; 1994 May; 15(5):901-5. PubMed ID: 8200093
[TBL] [Abstract][Full Text] [Related]
2. Mucosa-specific DNA adducts in human small intestine: a comparison with the colon.
Hamada K; Umemoto A; Kajikawa A; Tanaka M; Seraj MJ; Nakayama M; Kubota A; Monden Y
Carcinogenesis; 1994 Nov; 15(11):2677-80. PubMed ID: 7955126
[TBL] [Abstract][Full Text] [Related]
3. DNA adducts in normal colonic mucosa from healthy controls and patients with colon polyps and colorectal carcinomas.
Jonsson C; Stål P; Sjöqvist U; Akerlund JE; Löfberg R; Möller L
Mutagenesis; 2010 Sep; 25(5):499-504. PubMed ID: 20551081
[TBL] [Abstract][Full Text] [Related]
4. Exposure to meat-derived carcinogens and bulky DNA adduct levels in normal-appearing colon mucosa.
Ho V; Brunetti V; Peacock S; Massey TE; Godschalk RWL; van Schooten FJ; Ashbury JE; Vanner SJ; King WD
Mutat Res Genet Toxicol Environ Mutagen; 2017 Sep; 821():5-12. PubMed ID: 28735743
[TBL] [Abstract][Full Text] [Related]
5. DNA adduct formation of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in liver, kidney and colo-rectum of rats.
Turesky RJ; Markovic J
Carcinogenesis; 1995 Sep; 16(9):2275-9. PubMed ID: 7554091
[TBL] [Abstract][Full Text] [Related]
6. High levels of DNA adducts in human colon are associated with colorectal cancer.
Pfohl-Leszkowicz A; Grosse Y; Carrière V; Cugnenc PH; Berger A; Carnot F; Beaune P; de Waziers I
Cancer Res; 1995 Dec; 55(23):5611-6. PubMed ID: 7585642
[TBL] [Abstract][Full Text] [Related]
7. An aromatic DNA adduct in colonic mucosa from patients with colorectal cancer.
Phillips DH; Hewer A; Grover PL; Jass JR
IARC Sci Publ; 1988; (89):368-71. PubMed ID: 3198222
[TBL] [Abstract][Full Text] [Related]
8. Bulky DNA adduct levels in normal-appearing colon mucosa, and the prevalence of colorectal adenomas.
Ho V; Peacock S; Massey TE; Godschalk RW; van Schooten FJ; Ashbury JE; Vanner SJ; King WD
Biomarkers; 2018 Dec; 23(8):735-741. PubMed ID: 29871536
[TBL] [Abstract][Full Text] [Related]
9. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
Randerath K; Liehr JG; Gladek A; Randerath E
IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
[TBL] [Abstract][Full Text] [Related]
10. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology.
Li D; Wang M; Dhingra K; Hittelman WN
Cancer Res; 1996 Jan; 56(2):287-93. PubMed ID: 8542582
[TBL] [Abstract][Full Text] [Related]
11. 32P-post-labelling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplification.
Pfau W; Brockstedt U; Söhren KD; Marquardt H
Carcinogenesis; 1994 May; 15(5):877-82. PubMed ID: 8200090
[TBL] [Abstract][Full Text] [Related]
12. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
Randerath K; Randerath E
J UOEH; 1989 Mar; 11 Suppl():368-86. PubMed ID: 2664950
[TBL] [Abstract][Full Text] [Related]
13. Detection of deoxyadenosine-4-aminobiphenyl adduct in DNA of human uroepithelial cells treated with N-hydroxy-4-aminobiphenyl following nuclease P1 enrichment and 32P-postlabeling analysis.
Hatcher JF; Swaminathan S
Carcinogenesis; 1995 Feb; 16(2):295-301. PubMed ID: 7859361
[TBL] [Abstract][Full Text] [Related]
14. Biochemical (postlabelling) methods for analysis of carcinogen-DNA adducts.
Randerath K; Randerath E; Agrawal HP; Reddy MV
IARC Sci Publ; 1984; (59):217-31. PubMed ID: 6443609
[TBL] [Abstract][Full Text] [Related]
15. Low diacylglycerol values in colonic adenomas and colorectal cancer.
Sauter G; Nerlich A; Spengler U; Kopp R; Pfeiffer A
Gut; 1990 Sep; 31(9):1041-5. PubMed ID: 2210451
[TBL] [Abstract][Full Text] [Related]
16. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues.
Wang M; Dhingra K; Hittelman WN; Liehr JG; de Andrade M; Li D
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):705-10. PubMed ID: 8877062
[TBL] [Abstract][Full Text] [Related]
17. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A
IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of 32P-postlabeling analysis of DNA from exfoliated oral mucosa cells as a means of monitoring exposure of the oral cavity to genotoxic agents.
Foiles PG; Miglietta LM; Quart AM; Quart E; Kabat GC; Hecht SS
Carcinogenesis; 1989 Aug; 10(8):1429-34. PubMed ID: 2502322
[TBL] [Abstract][Full Text] [Related]
19. Detection of malondialdehyde DNA adducts in human colorectal mucosa: relationship with diet and the presence of adenomas.
Leuratti C; Watson MA; Deag EJ; Welch A; Singh R; Gottschalg E; Marnett LJ; Atkin W; Day NE; Shuker DE; Bingham SA
Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):267-73. PubMed ID: 11895876
[TBL] [Abstract][Full Text] [Related]
20. DNA adduct formation by 2-amino-3-methylimidazo [4,5-f] quinoline (IQ) in rat colon.
Lin CX; Monden Y; Umemoto A
J Med Invest; 2001 Feb; 48(1-2):102-8. PubMed ID: 11286010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
